OrsoBio
Alex Nguyen, CPA, currently holds the position of Vice President Finance and Controller at OrsoBio since January 2024. Previously, Alex served as Vice President, Head of Finance and Corporate Secretary at StrideBio, Inc. from April 2022 to December 2023, and as Global Controller and Senior Finance Director at Brii Biosciences from January 2020 to March 2022, where an IPO occurred in July 2021. Prior experience includes Director of Technical Accounting and External Reporting at Parexel, Assurance Director at PricewaterhouseCoopers, and internships in various accounting roles at The Bonadio Group and Chubb Insurance. Academic qualifications include an MBA in Accounting and a B.S. in Accounting, both from Rochester Institute of Technology, along with education at Fork Union Military Academy and Watchung Hills Regional High School.
This person is not in any teams
OrsoBio
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.